Stay tuned, lots of retatrutide, orforglipron, cagrisema and multiple other trial results coming in May and June
Its part of it
It is the clients responsibility to consider current weather conditions when ordering medications
[68] reported that continuous GLP-1 infusion reduced foam cell formation and the development of atherosclerotic lesions in ApoE -/- mice
Clinical Evidence for Weight Loss and Metabolic Health A Phase 2 trial published in NEJM (2023) reported approximately 24.2% mean body weight reduction over 48 weeks at the highest dose, alongside improvements in fasting glucose, insulin sensitivity, triglycerides, and waist circumference
5 A diet built around whole foods, protein, fiber, and fewer ultra-processed foods may support a healthier gut environment